FDA Delays Health Claim Rule to April 2025 Impacting Food Labeling Standards

On March 6, the U.S. Food and Drug Administration announced a delay in the implementation of the final rule regarding the definition of “healthy” on food labels. Originally set to take effect on February 25, 2025, the new deadline is now April 28, 2025, to allow for a policy review, following a presidential memorandum issued on January 20, 2025. Despite the delay, the transition period remains unchanged, ending in 2028, which mandates that companies ensure compliance with the new labeling requirements.

The primary objectives of this final rule include several key updates. First, it clarifies under what circumstances the term "healthy" can be used as a nutrient content claim on human food labels, helping consumers identify foods that align with current dietary guidelines. Second, it establishes conditions for using the term "healthy" and its derivatives on food packaging, indicating that such claims suggest the food supports healthy eating habits.

Additionally, the rule sets forth a systematic evaluation standard to judge whether foods qualify for “healthy” labeling based on food groups and nutrient limits. The specified food groups include vegetables, fruits, dairy, grains, proteins, and oils as recommended in the 2020-2025 Dietary Guidelines.

Moreover, the rule introduces the concept of Food Group Equivalent (FGE), determining how many qualifying foods exist within each group based on their nutritional content. Products, including individual foods and mixed items, must meet specific limits on added sugars, saturated fats, and sodium to make health claims.

Notably, beverages like water, tea, and coffee, with fewer than 5 calories per serving, automatically qualify for health claims, encouraging manufacturers to label these drinks as healthy options. This update allows consumers to better recognize the health benefits of tea, enhancing its status globally and prompting manufacturers to innovate healthier, lower-calorie beverage options.

As the FDA rolls out this new regulation, Chinese tea companies are encouraged to respond proactively in areas like product innovation, brand building, and aligning with international standards, aiming to capture greater market share internationally.